首頁 > 市場調查報告書 > 製藥

醫藥品原料藥

植物原料藥市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按類型、按應用、地區和競爭細分

市場調查報告書

商品編碼

1326470

植物原料藥市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按類型、按應用、地區和競爭細分

Plant Based API Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Application, By Region and Competition

出版日期: 2023年08月01日 | 出版商:

TechSci Research | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於消費者對天然和永續產品的需求不斷成長，預計全球植物原料藥市場在預測期內將以驚人的速度成長。許多消費者越來越意識到他們使用的產品對環境的影響，並擴大尋求天然和永續的替代品。因此，許多製藥公司現在轉向植物原料藥來滿足這一需求並在市場中脫穎而出，從而支持全球植物原料藥市場的成長。

人們對植物藥物的興趣日益濃厚

傳統醫學長期以來依賴植物的治療特性，許多自然療法已被證明可以有效治療多種疾病。因此，人們對植物性藥物的開發越來越感興趣，而植物性 API 是這一趨勢的關鍵組成部分。這反過來又促進了各種植物藥物的開發，從而推動了全球植物活性藥物成分（API）市場的成長。例如，2018 年，美國食品和藥物管理局 (FDA) 批准了 Epidiolex，這是一種由大麻二酚 (CBD) 製成的藥物，大麻二酚是一種在大麻植物中發現的化合物。該藥物用於治療兩歲及以上患者的兩種罕見形式的癲癇，Lennox-Gastaut 症候群和 Dravet 症候群。 Epidiolex 的批准標誌著植物性藥物在西藥中使用的一個重要里程碑。同樣，2020年，FDA批准了Sutimlimab（一種由煙草植物製成的單克隆抗體）用於治療成年冷凝集素病（CAD）患者的溶血。 Sutimlimab是第一個獲得FDA批准的植物源單克隆抗體，是利用植物源藥物治療罕見疾病的重要一步。此外，2020 年，FDA 批准了 Ferriprox，一種鐵螯合劑，用於治療輸血鐵超負荷患者。 Ferriprox 由一種稱為去鐵酮的植物化合物製成，該化合物源自一種稱為黃熱病樹的植物。 Ferriprox 的批准為輸血鐵超負荷患者提供了一種新的治療選擇，這種情況可能發生在地中海貧血、鐮狀細胞性貧血和其他血液疾病患者中。

人們對植物性藥物的興趣日益濃厚，加上對植物性產品的需求不斷成長，肯定也會增加對植物性活性藥物成分的需求，從而支持全球植物性 API 市場的成長。

慢性病患病率增加

癌症、糖尿病和心臟病等慢性疾病正在增加，對新的有效治療方法的需求日益成長。植物原料藥已被證明具有廣泛的健康益處，包括抗炎和抗氧化特性，並被用於生產多種藥物。這反過來又促進了幾種用於治療這些慢性病的藥物或療法的植物性版本的推出，從而為未來幾年全球植物性 API 市場的成長創造了新的前景。例如，紫杉醇是一種化療藥物，用於治療各種癌症，包括乳腺癌、卵巢癌和肺癌。 2020年，植物性紫杉醇在印度上市。這種植物性版本是由紫杉樹製成的，幾個世紀以來，紫杉樹一直被用來治療各種疾病。植物性紫杉醇被認為比傳統合成紫杉醇更具永續性，因為它是使用可再生資源生產的。同樣，地高辛是一種用於治療心力衰竭和某些心律失常的藥物。 2021 年，植物性版本的地高辛在印度上市。植物性版本是由一種叫做毛地黃的植物製成的，這種植物已經在傳統醫學中使用了幾個世紀。植物性地高辛被視為比使用石化產品生產的合成地高辛更永續的替代品。

生物技術和基因組學的進展

基因組學和生物技術的進步使得能夠鑑定和分離負責在植物中產生活性化合物的特定基因。這導致了能夠產生更多活性化合物的新植物品種的開發，這些化合物可用於開發新的植物原料藥，從而支持全球植物原料藥市場的成長。這也吸引了全球各大大小公司的關注，紛紛投資該領域，從而支持全球植物原料藥市場的成長。例如，以色列生物技術公司 Kaiima Bio-Agritech 開發了一個作物遺傳改良平台，用於生產高價值的植物原料藥，而加拿大生物技術公司 Ceapro 開發了一種從植物中提取活性成分的專有技術用於藥品和其他產品。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

其他市場參與者（最多五個）的詳細分析和概況分析。

商業概覽
產品供應
最近的發展
主要人員
SWOT分析
- Roquette Freres SA
- EVONIK Industries, AG
- Cargill, Inc.
- Kothari Phytochemicals & Industries Ltd
- Medipure Pharmaceuticals Inc.
- Centroflora Group
- Arboris, LLCs
- BASF SE
- Novartis AG
- Sanofi SA
- GlaxoSmithKline, plc
- F. Hoffmann-La Roche AG

第 16 章：戰略建議

簡介目錄

Product Code: 14866

Global Plant Based API Market is expected to grow at an impressive rate during the forecast period on account of the growing consumer demand for natural and sustainable products. Many consumers are becoming more conscious of the environmental impact of the products they use and are increasingly seeking out natural and sustainable alternatives. As a result, many pharmaceutical companies are now turning to plant-based APIs to meet this demand and differentiate themselves in the market, thereby supporting the growth of global plant based API market.

Plant-based APIs are derived from natural sources, such as herbs, spices, and other plants, and are used to produce a wide range of pharmaceuticals, including antibiotics, painkillers, and anticancer drugs. The growing demand for eco friendly products and need to achieve sustainability goals among countries and governments worldwide will create lucrative opportunities for the growth of global plant based API market in the next few years.

Another driver of the global plant-based API market is the growing interest in plant-based medicines. Traditional medicine has long relied on the healing properties of plants, and many of these natural remedies have been shown to be effective in treating a wide range of ailments. As a result, there is growing interest in the development of plant-based medicines, and plant-based APIs are a key component of this trend.

Growing Interest in Plant Based Medicines

Traditional medicine has long relied on the healing properties of plants, and many of these natural remedies have been shown to be effective in treating a wide range of ailments. As a result, there is a growing interest in the development of plant-based medicines, and plant-based APIs are a key component of this trend. This has in turn led to the development of various plant based pharmaceuticals thereby driving the growth of global plant based active pharmaceutical ingredient (API) market. For instance, in 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex, a drug made from cannabidiol (CBD), a compound found in the cannabis plant. This drug is used to treat two rare forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. The approval of Epidiolex marked a significant milestone in the use of plant-based pharmaceuticals in Western medicine. Similarly, in 2020, the FDA approved Sutimlimab, a monoclonal antibody made from tobacco plants, for the treatment of hemolysis in adult patients with cold agglutinin disease (CAD). Sutimlimab is the first plant-based monoclonal antibody to receive FDA approval, and it is a significant step forward in the use of plant-based pharmaceuticals for the treatment of rare diseases. Additionally, in 2020, the FDA approved Ferriprox, an iron chelator used to treat patients with transfusional iron overload. Ferriprox is made from a plant-based compound called deferiprone, which is derived from a plant called the yellow fever tree. The approval of Ferriprox provides a new treatment option for patients with transfusional iron overload, which can occur in patients with thalassemia, sickle cell anemia, and other blood disorders.

The increasing interest in plant based pharmaceuticals along with growing demand for plant based products will certainly increase the demand for plant based active pharmaceutical ingredients as well, thereby supporting the growth of global plant based API market.

Increasing Prevalence of Chronic Diseases

Chronic diseases such as cancer, diabetes, and heart disease are on the rise, and there is a growing need for new and effective treatments. Plant based APIs have been shown to have a wide range of health benefits, including anti-inflammatory and antioxidant properties, and are being used to produce a wide range of pharmaceuticals. This has in turn contributed to the launch of plant based versions of several medicine or therapies that are used to treat these chronic conditions, thereby creating new prospects for the growth of global plant based API market in the next few years. For instance, Paclitaxel is a chemotherapy drug used to treat various cancers, including breast, ovarian, and lung cancer. In 2020, a plant-based version of paclitaxel was launched in India. This plant-based version is made from yew trees, which have been used for centuries to treat various ailments. The plant-based version of paclitaxel is considered to be more sustainable than the traditional synthetic version, as it is produced using renewable resources. Similarly, Digoxin is a medication used to treat heart failure and certain heart rhythm disorders. In 2021, a plant-based version of digoxin was launched in India. The plant-based version is made from a plant called Digitalis lanata, which has been used in traditional medicine for centuries. The plant-based version of digoxin is seen as a more sustainable alternative to the synthetic version, which is produced using petrochemicals.

Advances in Biotechnology and Genomics

The advancement in genomics and biotechnology has enabled the identification and isolation of specific genes responsible for the production of active compounds in plants. This has led to the development of new plant varieties that produce higher quantities of active compounds, which can be used to develop new plant-based APIs, thereby supporting the growth of global plant based API market. This has also attracted the focus of various small and big companies worldwide making investment into this space and hence supporting the growth of global plant based API market. For example, Israeli biotech company Kaiima Bio-Agritech has developed a platform for the genetic improvement of crops for the production of high-value plant-based APIs, while Canadian biotech company Ceapro has developed a proprietary technology for the extraction of active ingredients from plants for use in pharmaceuticals and other products.

Market Segmentation

Global Plant Based API Market can be segmented by type, by application, and by region. Based on type, the Global Plant Based API market can be categorized into alkaloids, anthocyanins, flavonoids, phenolic acids, terpenoids, lignans and stilbenes, and others. By application, the Global Plant Based API market can be fragmented into pharmaceuticals, nutraceuticals, herbal based industries, and others. Regionally, the Global Plant Based API market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Roquette Freres SA, EVONIK Industries, AG, Cargill, Inc., Kothari Phytochemicals & Industries Ltd, Medipure Pharmaceuticals Inc., Centroflora Group, Arboris, LLCs, BASF SE, Novartis AG, Sanofi SA, GlaxoSmithKline, plc, F. Hoffmann-La Roche AG, among others are some of the leading players operating in the Global Plant Based API market.

Recent Developments

In 2019, a team of researchers from the University of Wisconsin-Madison developed a new platform for producing plant-based APIs using genetically modified tobacco plants. The researchers were able to produce an anti-inflammatory protein called Interleukin-37 (IL-37) in tobacco plants and demonstrated that the protein was able to alleviate symptoms of inflammatory bowel disease in mice.
In 2019, Sanofi SA announced a USD 640 million (€600 million) investment in its French production sites, with a focus on plant-based APIs for the treatment of rare diseases. The investment will support the development of new plant-based technologies, including the use of algae and other microorganisms to produce APIs. Sanofi has also invested in the production of plant-based insulin, which was approved by the FDA in 2020.
Novartis has also made significant investments in plant-based APIs in recent years, with a focus on the use of plant cell culture technology. In 2020, Novartis announced a collaboration with Canadian biotech company PlantForm Corporation to develop plant-based biosimilars for the treatment of rare diseases. Novartis has also invested in the development of plant-based vaccines, including a collaboration with Boston-based biotech company VBI Vaccines to develop a plant-based vaccine for COVID-19.
In 2020, Amyris, a California-based biotechnology company, announced that it had successfully produced a plant-based version of the anti-malarial drug artemisinin. The company used a proprietary yeast strain to produce the drug, which was then licensed to pharmaceutical companies for further development and commercialization.
In 2021, researchers from the University of Bristol developed a method for producing a key component of the malaria drug artemisinin using genetically modified yeast. This approach offers a more sustainable and cost-effective alternative to traditional methods of producing the drug, which involve extracting it from the artemisia plant

Report Scope:

In this report, Global Plant Based API Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Plant Based API Market, By Type:

Alkaloids
Anthocyanins
Flavonoids
Phenolic Acids
Terpenoids
Lignans and Stilbenes
Others

Plant Based API Market, By Application:

Pharmaceuticals
Nutraceuticals
Herbal Based Industries
Others

Plant Based API Market, By Region:

North America
- United States
- Canada
- Mexico

Europe
- France
- Germany
- United Kingdom
- Italy
- Spain

Asia Pacific
- China
- India
- Japan
- South Korea
- Australia

South America
- Brazil
- Argentina
- Colombia

Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Plant Based API Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Plant Based API Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Alkaloids, Anthocyanins, Flavonoids, Phenolic Acids, Terpenoids, Lignans and Stilbenes, Others)
- 5.2.2. By Application (Pharmaceuticals, Nutraceuticals, Herbal Based Industries, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2022)
5.3. Product Map
- 5.3.1. By Type
- 5.3.2. By Application
- 5.3.3. By Region

6. North America Plant Based API Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Plant Based API Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Application
- 6.3.2. Canada Plant Based API Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Application
- 6.3.3. Mexico Plant Based API Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Application

7. Europe Plant Based API Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Plant Based API Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Application
- 7.3.2. Germany Plant Based API Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Application
- 7.3.3. United Kingdom Plant Based API Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Application
- 7.3.4. Italy Plant Based API Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Application
- 7.3.5. Spain Plant Based API Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Application

8. Asia-Pacific Plant Based API Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Plant Based API Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Application
- 8.3.2. India Plant Based API Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Application
- 8.3.3. Japan Plant Based API Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Application
- 8.3.4. South Korea Plant Based API Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Application
- 8.3.5. Australia Plant Based API Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Application

9. South America Plant Based API Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Plant Based API Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Application
- 9.3.2. Argentina Plant Based API Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Application
- 9.3.3. Colombia Plant Based API Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Application

10. Middle East and Africa Plant Based API Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Plant Based API Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Application
- 10.3.2. Saudi Arabia Plant Based API Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Application
- 10.3.3. UAE Plant Based API Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Global Plant Based API Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
- 15.5.1. Roquette Freres SA
- 15.5.2. EVONIK Industries, AG
- 15.5.3. Cargill, Inc.
- 15.5.4. Kothari Phytochemicals & Industries Ltd
- 15.5.5. Medipure Pharmaceuticals Inc.
- 15.5.6. Centroflora Group
- 15.5.7. Arboris, LLCs
- 15.5.8. BASF SE
- 15.5.9. Novartis AG
- 15.5.10. Sanofi SA
- 15.5.11. GlaxoSmithKline, plc
- 15.5.12. F. Hoffmann-La Roche AG